Protecting patients with IBD during the COVID-19 pandemic

Affiliations

¹ IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan 20089, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
² Department of Gastroenterology, Nancy University Hospital, Vandoeuvre-les-Nancy, France; Inserm U1256 NGERE, Lorrraine University, Vandoeuvre-les-Nancy, France.
³ IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan 20089, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Electronic address: silvio.danese@hunimed.eu.

Comment

Gionata Fiorino et al. Lancet Gastroenterol Hepatol. 2020 Jul.

. 2020 Jul;5(7):639.

doi: 10.1016/S2468-1253(20)30152-7. Epub 2020 May 20.

¹ IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan 20089, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
² Department of Gastroenterology, Nancy University Hospital, Vandoeuvre-les-Nancy, France; Inserm U1256 NGERE, Lorrraine University, Vandoeuvre-les-Nancy, France.
³ IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan 20089, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Electronic address: silvio.danese@hunimed.eu.

No abstract available

Comment on

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China.
An P, Ji M, Ren H, Su J, Ding NS, Kang J, Yin A, Zhou Q, Shen L, Zhao L, Jiang X, Xiao Y, Tan W, Lv X, Li J, Liu S, Zhou J, Chen H, Xu Y, Liu J, Chen M, Cao J, Zhou Z, Shen L, Tan S, Yu H, Dong W, Ding Y. An P, et al. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525-527. doi: 10.1016/S2468-1253(20)30121-7. Epub 2020 Apr 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32311321 Free PMC article. No abstract available.

1. An P, Ji M, Ren H. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China. Lancet Gastroenterol Hepatol. 2020;5:525–527. - PMC - PubMed
1. Fiorino G, Allocca M, Furfaro F. Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience. J Crohns Colitis. 2020 doi: 10.1093/ecco-jcc/jjaa058. published online March 24. - DOI - PMC - PubMed
1. Danese S, Cecconi M, Spinelli A. Management of IBD during the COVID-19 outbreak: resetting clinical priorities. Nat Rev Gastroenterol Hepatol. 2020 doi: 10.1038/s41575-020-0294-8. published online March 25. - DOI - PMC - PubMed
1. Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;45:3–13. - PubMed
1. Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J. Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease. Gastroenterology. 2015;149:1716–1730. - PubMed